Zmapp | search
Click here to view Zmapp news from 60+ newspapers.
Bookmark or Share- Reversion of advanced Ebola virus disease in nonhuman primates with ZMappNature - This study shows that ZMapp, an optimized cocktail of three monoclonal antibodies that has been pressed into clinical use in response to the current Ebola virus disease epidemic, was...
- A Randomized, Controlled Trial of ZMapp for Ebola Virus Infectionbody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD). METHODS Beginning in March 2015, we conducted a randomized, controlled trial of ZMapp
- Study finds Ebola treatment ZMapp holds promise, although results not ...ZMapp, developed by Mapp Biopharmaceutical, Inc., based in San Diego, is composed of three different laboratory-made proteins called monoclonal antibodies. The treatment is designed to prevent the progression of EVD within the body by targeting the main surface protein of the Ebola virus.
- New antibodies best ZMapp in Ebola trial | Nature BiotechnologyZMapp, the only candidate drug previously studied in Ebola patients, was being used as the control arm in PALM because it showed a favorable survival trend in an earlier trial.
- A Randomized, Controlled Trial of ZMapp for Ebola Virus InfectionData from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD). Beginning in March 2015, we...
More
